par Fimereli, Danai 
;Venet, David ;Rediti, Mattia ;Boeckx, Bram;Maetens, Marion ;Majjaj, Samira ;Rouas, Ghizlane;Marchio, Caterina;Bertucci, François;Mariani, Odette;Capra, Maria;Bonizzi, Giuseppina;Contaldo, Federica;Galant, Christine;Van den Eynden, Gert;Salgado, Roberto;Biganzoli, Elia;Vincent-Salomon, Anne;Pruneri, Giancarlo;Larsimont, Denis ;Lambrechts, Diether;Desmedt, Christine ;Brown, David Norman ;Rothé, Françoise ;Sotiriou, Christos
Référence EBioMedicine, 82, page (104169)
Publication Publié, 2022-08-01
;Venet, David ;Rediti, Mattia ;Boeckx, Bram;Maetens, Marion ;Majjaj, Samira ;Rouas, Ghizlane;Marchio, Caterina;Bertucci, François;Mariani, Odette;Capra, Maria;Bonizzi, Giuseppina;Contaldo, Federica;Galant, Christine;Van den Eynden, Gert;Salgado, Roberto;Biganzoli, Elia;Vincent-Salomon, Anne;Pruneri, Giancarlo;Larsimont, Denis ;Lambrechts, Diether;Desmedt, Christine ;Brown, David Norman ;Rothé, Françoise ;Sotiriou, Christos Référence EBioMedicine, 82, page (104169)
Publication Publié, 2022-08-01
Article révisé par les pairs
| Résumé : | Late distant recurrence is a challenge for the treatment of invasive lobular carcinoma (ILC) of the breast. Despite in-depth characterisation of primary ILC, the molecular landscape of metastatic ILC is still only partially understood. |
